TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model.

Maio, Nunziata; Cherry, Sara; Schultz, David C; Hurst, Brett L; Linehan, W Marston; Rouault, Tracey A

Maio, Nunziata; Cherry, Sara; Schultz, David C; Hurst, Brett L; Linehan, W Marston; Rouault, Tracey A.

Afiliação

Maio N; Molecular Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Cherry S; Department of Pathology and Laboratory Medicine, Chemogenomic Discovery Program. University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
Schultz DC; Department of Biochemistry and Biophysics, High-throughput Screening Core, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
Hurst BL; Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA.
Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Rouault TA; Molecular Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

iScience ; 25(10): 105074, 2022 Oct 21.

Article em En | MEDLINE | ID: mdl-36093377

Palavras-chave

Health sciences; pharmacology; virology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google